The Alphavax Pipeline Is Targeting Pandemic Influenza And Cytomegaloviruscmv As Well As Grant And Collaborator Supported Programs In Hivprostate And Breast Cancerand Several Biodefense Vaccinesclinical Data From The First Alphavaccine Human Trials Have Confirmed Safety And Immunological Activity In Manthese Immune Responses Are Characterized As Robust And Balanced Antibodyb Celland Cellulart Cellimmune Responsesconfirming The Promising Data We Have Obtained In Over A Decade Of Intensive Pre Clinical Work With This Vector Platform
